Clinical Trial Detail

NCT ID NCT03547999
Title A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Darren Carpizo, MD
Indications

colorectal cancer

Therapies

Nivolumab + mFOLFOX-6

CV301 + Nivolumab + mFOLFOX6

Age Groups: adult senior

No variant requirements are available.